Prevalence of Supine Hypertension in Alpha‐Synucleinopathies: A Systematic Review and Meta‐Analysis
Movement Disorders Clinical Practice · 2025-11 · 12 (11) · 1703-1713
DOI: 10.1002/mdc3.70142 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 23.05.2025. Verfasst von Paulo Roberto Moss Lopes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Surgery, School of Medicine, Federal University of Amazonas (UFAM), Manaus, Brazil. Hauptthemen laut MEDLINE: Hypertension, Hypotension, Orthostatic, Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Alpha‐synucleinopathies, including Parkinson's Disease (PD), Dementia with Lewy Bodies (DLB), Multiple System Atrophy (MSA), and Pure Autonomic Failure (PAF), are associated with autonomic dysfunctions such as orthostatic hypotension (OH) and supine hypertension (SH). SH, characterized by elevated supine blood pressure, carries significant cardiovascular and cognitive risks, yet its prevalence in α‐synucleinopathies remains inadequately defined.
Objectives
We aimed to conduct a systematic review and meta‐analysis to assess the prevalence of SH in α‐synucleinopathies.
Methods
We systematically searched PubMed, Embase, and Web of Science databases for studies reporting SH prevalence in patients with α‐synucleinopathies. A random‐effects model estimated prevalence, stratified by disease type, study design, SH definition, OH presence, and disease duration. Sensitivity analyses were applied to explore sources of variability.
Results
Nineteen studies involving 4973 patients were included. The overall SH prevalence was 30.4% (95% CI: 26.4–34.7; I 2 = 87.6%). In PD, SH prevalence was 28.3% (95% CI: 24.0–32.9; I 2 = 86.4%), with OH significantly increasing prevalence (33.9% vs. 21.3%, P = 0.0341). In MSA, SH prevalence was 31.1% (95% CI: 25.9–36.9; I 2 = 30.5%), with OH similarly associated with higher SH prevalence (46.5% vs. 19.8%, P = 0.0023). In DLB, the pooled SH prevalence was 48.7% (95% CI: 39.5–58.1; I 2 = 11.9%). For PAF, a single study reported a prevalence of 48.4% (95% CI: 35.7–61.2).
Conclusion
SH is highly prevalent across α‐synucleinopathies, with variability by disease type and OH presence. Standardizing diagnostic criteria and investigating its clinical implications are essential to enhance management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Surgery, School of Medicine, Federal University of Amazonas (UFAM), Manaus, Brazil.
- Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
- Movement Disorders Center, Department of Neurology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
- Hospital Israelita Albert Einstein, São Paulo, Brazil.
ORCID-Profile: Paulo Roberto Moss Lopes, Jacy Bezerra Parmera
Zitieren
APA
Moss Lopes, P. R., Westphal Filho, F. L., Mendes Filho, F. S. M., Falcão, C. E. R., Arca, V. M., & Parmera, J. B. (2025). Prevalence of Supine Hypertension in Alpha‐Synucleinopathies: A Systematic Review and Meta‐Analysis. Movement Disorders Clinical Practice, 12(11), 1703-1713. https://doi.org/10.1002/mdc3.70142
Vancouver
Moss Lopes PR, Westphal Filho FL, Mendes Filho FSM, Falcão CER, Arca VM, Parmera JB. Prevalence of Supine Hypertension in Alpha‐Synucleinopathies: A Systematic Review and Meta‐Analysis. Movement Disorders Clinical Practice. 2025;12(11):1703-1713. doi:10.1002/mdc3.70142
BibTeX
@article{MossLopes2025,
author = {Moss Lopes, Paulo Roberto and Westphal Filho, Fernando Luiz and Mendes Filho, Frederico De Sousa Marinho and Falcão, Caio Eduardo Rodrigues and Arca, Vitor Maia and Parmera, Jacy Bezerra},
title = {Prevalence of Supine Hypertension in Alpha‐Synucleinopathies: A Systematic Review and Meta‐Analysis},
journal = {Movement Disorders Clinical Practice},
year = {2025},
volume = {12},
number = {11},
pages = {1703--1713},
doi = {10.1002/mdc3.70142}
}
EUVIMED